摘要
1 INTRODUCTION Cardiovascular disease(CVD)is the most common noncommunicable disease and the leading cause of death globally.l It has resulted in enormous economic and social burdens,while posing a ggreat challenge for the prevention and control of CvD worldwide,especially in China.Assessment and management of cardiovascular risk is the foundation of CvD prevention,and is strongly recommended by guidelines.Additionally,it can help screen the target population who would benefit most from the lower-cost intervention,while informing them the cardiovascular risk,which will help in promoting self-management.It can also guide doctors in making logical management decisions,and implement precision prevention and treatment strategies to reduce the CVD burden.2,4 Therefore,it is a key approach in achieving the goals of"Good Health and Well-being"in the United Nations and"Healthy China 2030"in China.
基金
Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences,Grant/Award Numbers:2021-I2M-1-010,2019-I2M-2-003
National High-Level Hospital Clinical Research Funding,Grant/Award Numbers:2022-GSP-GG-1,2022-GSP-GG-2
National Clinical Research Center for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences,Grant/Award Number:NCRC2020006。
